SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: S Shaw who wrote (11568)7/15/1998 9:24:00 PM
From: Bill Wexler  Read Replies (2) | Respond to of 18691
 
I know that fast-track application is a matter of public record. Zonagen can now forget about fast-track (besides, it would only help the short-sellers since we would simply get to a rejection faster). I'm not sure about the "back burner" thing. Anyone else care to comment?



To: S Shaw who wrote (11568)7/16/1998 1:51:00 AM
From: BDR  Respond to of 18691
 
<<What kind of time frame are we looking at for the FDA to process the
ZONA NDA? >>

From the Zonagen press release posted here:

exchange2000.com

"Zonagen said it expects to hear from the FDA within 60 days
as to whether its application was accepted for evaluation, and
the FDA could issue a decision on the drug within the next 14
months."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News